Compare BSEM & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSEM | MGF |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 88.1M |
| IPO Year | 2026 | N/A |
| Metric | BSEM | MGF |
|---|---|---|
| Price | $1.15 | $13.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 155.2K | 19.3K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $87.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $2.64 |
| 52 Week High | $5.44 | $13.99 |
| Indicator | BSEM | MGF |
|---|---|---|
| Relative Strength Index (RSI) | 23.28 | 88.38 |
| Support Level | N/A | $13.30 |
| Resistance Level | $4.65 | $13.66 |
| Average True Range (ATR) | 0.24 | 0.15 |
| MACD | -0.01 | -0.31 |
| Stochastic Oscillator | 8.73 | 73.46 |
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
Aberdeen Government Markets Income Fund is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income, but it may also consider capital appreciation.